Evidence map›Paper›PMID 38027845›Full record

ArticleHeliyon2023

COVID-19 in a Portuguese whole blood donor population.

Liliana Fonseca, Filipa Martins Pereira, Luís Moura, Arnaldo Brito, Filipe Lobo, Ana Palmira Amaral, Marina Costa

Open access · goldAbstract read
In one paragraph

Article in Heliyon, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 75% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Liliana FonsecaServiço de Sangue e Medicina Transfusional, Centro Hospitalar Tondela-Viseu, Portugal.
Filipa Martins PereiraServiço de Imunohemoterapia, Centro Hospitalar Universitário de Santo António, Portugal.
Luís MouraServiço de Sangue e Medicina Transfusional, Centro Hospitalar Tondela-Viseu, Portugal.
Arnaldo BritoServiço de Sangue e Medicina Transfusional, Centro Hospitalar Tondela-Viseu, Portugal.
Filipe LoboServiço de Sangue e Medicina Transfusional, Centro Hospitalar Tondela-Viseu, Portugal.
Ana Palmira AmaralServiço de Sangue e Medicina Transfusional, Centro Hospitalar Tondela-Viseu, Portugal.
Marina CostaServiço de Sangue e Medicina Transfusional, Centro Hospitalar Tondela-Viseu, Portugal.
Centro Hospitalar Tondela-Viseu · PTHospital de Santo António · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coronavirus disease 2019 (COVID-19) is an infectious disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), leading to pneumonia and acute respiratory distress syndrome. The COVID-19 pandemic had a major impact on the stock of blood banks worldwide. This study aims to assess the prevalence of COVID-19 in a population of whole blood donors and analyze the possible association between blood group and susceptibility to the disease and the impact of adopting preventive measures against SARS-CoV-2 infection.

Indexed as

Blood groupCOVID-19PandemicPrevalenceWhole blood donors

Identifiers

PMID38027845
PMCPMC10651442
OpenAlexW4387261680

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.